CINJ Clinical Investigations & Precision Therapeutics Research Program-Preclinical evaluation of inhibitors to PD-L1 and gltamatergic signaling, Suzie Chen and Discovery of Small Molecule Inhibitors of PD-1/PD-L1 and Keap1/Nrf2 Protein-Protein Interactions, Longqin (Long) Hu. Rutgers Cancer Institute of New Jersey, Auditorium B, 195 Little Albany Street, New Brunswick.